Colony stimulating factor-1 (CSF-1), a polypeptide chain cytokine, through its receptor (CSF-1R) regulates the differentiation of macrophages. Recently, the promising therapeutic potential of ...
In this narrative and critical review, we aim to see the potential use of immune cells modulation or cell therapy as therapeutic alternatives to OA patients. Macrophages are immune cells that are ...
has recently been recognised as a disease of impaired alveolar macrophage function caused by neutralising anti-granulocyte-macrophage colony-stimulating (anti-GM-CSF) autoantibodies. Subcutaneous ...
Here, we investigated the role and source of granulocyte macrophage-colony-stimulating factor (GM-CSF) in the differentiation of synovial infDC in RA. Methods Production of GM-CSF by peripheral blood ...
These TAMs are polarized toward the M2 phenotype by CSF-1 and CCL2 ... Cite this: Tumor-associated Macrophages in Breast Cancer as Potential Biomarkers for New Treatments and Diagnostics ...
kuleuven.be Intestinal resident macrophages are at the front line of host defence at the mucosal barrier within the gastrointestinal tract and have long been known to play a crucial role in the ...
7 天
MyChesCo on MSNSavara Inc. Publishes Promising Long-Term Outcomes for aPAP TreatmentLANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the publication of a manuscript detailing long-term outcomes for molgramostim inhalation solution in patients with autoimmune pulmonary ...
LANGHORNE, Pa. - Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases with a ...
Constantly updated IP Blocklists (for any firewall, host file), ConfigServer Firewall (CSF) setup guides, CSF dark theme, and adds support for Docker and OpenVPN to CSF. Includes Traefik integration ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果